These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 5985298)

  • 41. [Nucleolus segregation of tumor cells induced by actinomycin K and lycobetaine (author's transl)].
    Wang ZW; Shu RS; Xu B
    Zhongguo Yao Li Xue Bao; 1982 Mar; 3(1):48-51. PubMed ID: 6178253
    [No Abstract]   [Full Text] [Related]  

  • 42. [The anticancer and pharmacologic study of oxalysine (author's transl)].
    Yue XF; Wu FG; Xu B
    Yao Xue Xue Bao; 1980 Jul; 15(7):391-5. PubMed ID: 6775491
    [No Abstract]   [Full Text] [Related]  

  • 43. [Stability of Act. olivoreticuli--producer of olivomycin--during storage on solid organic substrate].
    Parfenova AI; Sitnikova LV; Gudkova TP; Abramenko IN; Bykov EV
    Antibiotiki; 1968 Nov; 13(11):978-82. PubMed ID: 5712472
    [No Abstract]   [Full Text] [Related]  

  • 44. Antitumor activity of leptomycin B.
    Komiyama K; Okada K; Tomisaka S; Umezawa I; Hamamoto T; Beppu T
    J Antibiot (Tokyo); 1985 Mar; 38(3):427-9. PubMed ID: 4008334
    [No Abstract]   [Full Text] [Related]  

  • 45. Isolation and characterization of lymphomycin.
    Ishida N; Suzuki F; Maeda H; Ozu K; Kumagai K
    J Antibiot (Tokyo); 1969 May; 22(5):218-27. PubMed ID: 5811395
    [No Abstract]   [Full Text] [Related]  

  • 46. [Antagonistic properties of some species of Micromonospora].
    Shvesnikova MA; Maksimova TS; Kudrina ES; Ol'khovatova OL; Kovshvarova IN
    Antibiotiki; 1971 Nov; 16(11):966-8. PubMed ID: 5147756
    [No Abstract]   [Full Text] [Related]  

  • 47. [Microbiological characteristics of actinomycetes, growth inhibitors of malignant tumour tissue cultures].
    Kaliuzhna LD; Frolov AF
    Mikrobiol Zh; 1965; 27(5):10-6. PubMed ID: 5868316
    [No Abstract]   [Full Text] [Related]  

  • 48. Cytotoxic and antitumor antibiotics produced by microorganisms.
    Fuska J; Proksa B
    Adv Appl Microbiol; 1976; 20():259-370. PubMed ID: 998366
    [No Abstract]   [Full Text] [Related]  

  • 49. Chemical and biological aspects of sparsomycin, an antibiotic from Streptomyces.
    Ottenheijm HC; van den Broek LA; Ballesta JP; Zylicz Z
    Prog Med Chem; 1986; 23():219-68. PubMed ID: 3310108
    [No Abstract]   [Full Text] [Related]  

  • 50. Hedamycin, a new antitumor antibiotic. II. Biological properties.
    Bradner WT; Heinemann B; Gourevitch A
    Antimicrob Agents Chemother (Bethesda); 1966; 6():613-8. PubMed ID: 5985297
    [No Abstract]   [Full Text] [Related]  

  • 51. In vitro and in vivo effects of differanisole A on some tumor cells.
    Suzuki T; Oka H; Okura A; Asahi K; Takahashi N
    J Antibiot (Tokyo); 1986 Jun; 39(6):869-71. PubMed ID: 3090000
    [No Abstract]   [Full Text] [Related]  

  • 52. [Effect of anticancer antibiotics on formation of hemolysins under experimental conditions].
    Liashenko VA; Kolesnikova LP
    Antibiotiki; 1965 Sep; 10(9):808-16. PubMed ID: 5872778
    [No Abstract]   [Full Text] [Related]  

  • 53. [Actinoxanthin. Purification and biological properties].
    Khokhlov AS; Cherches BZ; Reshetov PD; Smirnova GM; Koloditskaia TA
    Izv Akad Nauk SSSR Biol; 1970; 5():755-63. PubMed ID: 5498403
    [No Abstract]   [Full Text] [Related]  

  • 54. [Experimental study of a mitostatic antibiotic: rufochromomycin (R.P. 5,278)].
    Maral R; Ganter P
    Bull Cancer; 1966; 53(2):201-27. PubMed ID: 5961924
    [No Abstract]   [Full Text] [Related]  

  • 55. Hypomethylating Chemotherapeutic Agents as Therapy for Myelodysplastic Syndromes and Prevention of Acute Myeloid Leukemia.
    Sorrentino VG; Thota S; Gonzalez EA; Rameshwar P; Chang VT; Etchegaray JP
    Pharmaceuticals (Basel); 2021 Jul; 14(7):. PubMed ID: 34358067
    [TBL] [Abstract][Full Text] [Related]  

  • 56. RNA-dependent inhibition of ribonucleotide reductase is a major pathway for 5-azacytidine activity in acute myeloid leukemia.
    Aimiuwu J; Wang H; Chen P; Xie Z; Wang J; Liu S; Klisovic R; Mims A; Blum W; Marcucci G; Chan KK
    Blood; 2012 May; 119(22):5229-38. PubMed ID: 22517893
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The in vivo activity of combinations of 5-azacytidine and cytidine on leukemia L-1210.
    Evans JS; Hanka LJ
    Experientia; 1968 Sep; 24(9):922-3. PubMed ID: 5715449
    [No Abstract]   [Full Text] [Related]  

  • 58. Biogenetic amino acid antagonists.
    Nass G; Poralla K; Zähner H
    Naturwissenschaften; 1971 Dec; 58(12):603-8. PubMed ID: 5147800
    [No Abstract]   [Full Text] [Related]  

  • 59. U-42, 126, a new antimetabolite antibiotic: production, biological activity, and taxonomy of the producing microorganism.
    Hanka LJ; Dietz A
    Antimicrob Agents Chemother; 1973 Mar; 3(3):425-31. PubMed ID: 4790601
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 5-Azacytidine and 5-aza-2'-deoxycytidine behave as different antineoplastic agents in B16 melanoma.
    Cortvrindt R; Bernheim J; Buyssens N; Roobol K
    Br J Cancer; 1987 Sep; 56(3):261-5. PubMed ID: 2444244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.